The cholangiocarcinoma treatment market — therapies for a rare and historically difficult-to-treat bile duct cancer with dismal outcomes in advanced stages — has been transformed over the past five years by the arrival of genomically-targeted therapies, with the Cholangiocarcinoma Treatment Market reflecting a biliary tract cancer market projected to grow at a compound annual growth...